InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.011

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Strategic Review of Cynata Clinical Development Portfolio 24 Jul 2023 9:39AM $0.135 $0.011 fallen by 91.85%
$3 Initial Director's Interest Notice - David Atkins 3 Jul 2023 1:28PM $0.115 $0.011 fallen by 90.43%
$3 Initial Director's Interest Notice - Kilian Kelly 3 Jul 2023 1:27PM $0.115 $0.011 fallen by 90.43%
$3 Final Director's Interest Notice - Stewart Washer 3 Jul 2023 1:27PM $0.115 $0.011 fallen by 90.43%
$3 Final Director's Interest Notice - Ross Macdonald 3 Jul 2023 1:24PM $0.115 $0.011 fallen by 90.43%
$3 Notification regarding unquoted securities - CYP 30 Jun 2023 1:10PM $0.120 $0.011 fallen by 90.83%
$3 Proposed issue of securities - CYP 30 Jun 2023 9:44AM $0.125 $0.011 fallen by 91.20%
$3 Cynata announces CEO succession and Board changes 30 Jun 2023 9:13AM $0.125 $0.011 fallen by 91.20%
$3 Change in substantial holding 15 Jun 2023 8:23AM $0.140 $0.011 fallen by 92.14%
$3 Appendix 3Ys x 6 1 Jun 2023 4:23PM $0.135 $0.011 fallen by 91.85%
$3 Top 20 Listed Optionholders & Distribution Schedule 1 Jun 2023 9:51AM $0.135 $0.011 fallen by 91.85%
$3 Application for quotation of securities - CYP 1 Jun 2023 9:48AM $0.135 $0.011 fallen by 91.85%
$3 Cleansing Notice 31 May 2023 12:55PM $0.140 $0.011 fallen by 92.14%
$3 Application for quotation of securities - CYP 31 May 2023 12:53PM $0.140 $0.011 fallen by 92.14%
$3 Results of Meeting 25 May 2023 11:04AM $0.140 $0.011 fallen by 92.14%
$3 Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT 22 May 2023 10:22AM $0.150 $0.011 fallen by 92.67%
$3 Application for quotation of securities - CYP 11 May 2023 9:57AM $0.165 $0.011 fallen by 93.33%
$3 Cynata Completes Oversubscribed Share Purchase Plan 10 May 2023 12:54PM $0.165 $0.011 fallen by 93.33%
$3 Quarterly Activity Report & Appendix 4C 28 Apr 2023 12:46PM $0.185 $0.011 fallen by 94.05%
$3 Proposed issue of securities - CYP 24 Apr 2023 12:14PM $0.180 $0.011 fallen by 93.89%
$3 Letter to Shareholders, Notice of Meeting & Proxy Form 24 Apr 2023 10:52AM $0.190 $0.011 fallen by 94.21%
$3 Cleansing Notice 24 Apr 2023 9:39AM $0.190 $0.011 fallen by 94.21%
$3 Application for quotation of securities - CYP 24 Apr 2023 9:36AM $0.190 $0.011 fallen by 94.21%
$3 Target Market Determination 19 Apr 2023 4:27PM $0.205 $0.011 fallen by 94.63%
$3 Share Purchase Plan Booklet & Option Prospectus 19 Apr 2023 3:42PM $0.195 $0.011 fallen by 94.36%

176 - 200 of 703 results

Page 8 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.